Exosome therapy utilizes nano-sized particles called exosomes, which carry proteins, lipids, and RNA to facilitate intercellular communication. These exosomes can promote tissue regeneration and modulate immune responses.

Our exosomes are derived from Wharton’s Jelly, sourced from healthy, full-term C-section births.

The timeframe for observing results can vary depending on the individual and the condition being treated. Some patients may notice improvements within a few weeks, while others might require multiple sessions over several months to achieve desired outcomes.

No, our exosomes do not contain any genetic material or stem cells.

Most patients experience mild, short-term reactions, including redness and swelling at the injection site, mild tenderness or soreness, and temporary itching as the area heals. These reactions are normal and indicate that the body is responding to the treatment.

Our exosomes are highly concentrated, ensuring a consistent and potent product.

Our exosomes are shipped in dry ice via FedEx with next-day delivery available.

Exosome therapy is a minimally invasive regenerative medicine procedure that can help with many conditions, particularly those affecting the joints and soft tissue.

1. EFFICACY: Mesenchymal stem cells (MSC) with less than three generation production are the most effective. Imported lyophilized (freeze dried), plant or animal-based exosomes are NOT absorbed by the human body. 

1. 351(A) DRUG DESIGNATION VS 361 BIOLOGIC: Exosomes should have a 351(a) designation. An exosome which has a 351(a) drug designation means that the drug, in this case exosomes, have been registered with the FDA and are required to undergo a much more rigorous production process, allowing for injection or IV use. 

1. COA PROVIDED: The company should provide a Certificate of Analysis (COA). This should be provided by a known independent third-party testing company that tests for infectious agents, sterility, and safety. As well as certifying the amount of exosomes in each milliliter using the immune marker “CD81”. 

1. FDA MASTERFILE: Does the company have a FDA Masterfile? A FDA Masterfile indicates that the company has complied with the FDA regulatory policies surrounding exosomes and has submitted all of the data and testing information to the FDA for researchers and providers to reference. 

1. RESEARCH: Is the exosome company engaging in research that will be submitted to the FDA? 

Derived from Mesenchymal Stem Cells (MSCs), exosomes are tiny nanovesicles that play a crucial role in cell-to-cell communication, potentially influencing the body’s response to inflammation, injury, and healing. Notably, they are free from cellular DNA, lack replication capability or metabolic activity, and undergo rigorous testing to ensure compliance with safety and purity standards. Harnessing the power of 100 billion MSC exosomes, along with growth factors, peptides, coenzymes, amino acids, and minerals, SPORT may promote tissue repair, inflammation reduction and improved immune response. This may lead to a faster return to training and competition for injured athletes.